Navigation Links
VIVUS to Present at the 10th Annual Needham Healthcare Conference
Date:3/29/2011

MOUNTAIN VIEW, Calif., March 29, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the 10th Annual Needham Healthcare Conference.  

The VIVUS presentation will take place at the Palace Hotel in New York, New York on Tuesday, April 5, 2011 at 2:00 p.m. ET.  A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com. CONTACT:   VIVUS, Inc.Investor Relations: The Trout GroupTimothy E. Morris

Brian KorbChief Financial Officer

bkorb@troutgroup.com650-934-5200

646-378-2923
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Data on VIVUS QNEXA to be Presented in Six Posters at The Obesity Societys Annual Meeting
2. VIVUS to Present at Four Upcoming Investor Conferences
3. VIVUS to Present at Two Upcoming Investor Conferences
4. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
5. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
6. VIVUS to Present at Four Upcoming Healthcare Conferences
7. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
8. VIVUS to Present at the Needham and Company Life Sciences Conference
9. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
10. VIVUS Reports First Quarter 2009 Financial Results and Highlights
11. Chimerix to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Indiana (PRWEB) , ... April 18, 2017 , ... Alisa ... 2017 Distinguished Alumni Awards from the Purdue College of Pharmacy in Lafayette, Indiana. ... Purdue Pharmacy Program for achievements in their careers and other scientific endeavors. , ...
(Date:4/19/2017)... ... 19, 2017 , ... WHO: Peggy Lillis Foundation, the preeminent ... advocacy. Founded in 2010 in memory of a single-parent mom and kindergarten teacher ... the most-consulted source for patient-focused information on C. diff infections in the nation. ...
(Date:4/19/2017)... WESTMINSTER, Colo. , April 19, ... industry-leading specialty finance firm that provides senior debt ... announced the closing of a $20 million senior ... privately-held orthobiologics company engaged in the development and ... treatment of orthopedic injuries. Cerapedics, lead ...
(Date:4/18/2017)... Jordan, Utah (PRWEB) , ... April 18, 2017 ... ... and collaboration company, has been awarded Channel Partners 2017 Next-Gen Solution Provider. , ... create business value for customers with their vision, innovation, and advocacy of the ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):